Illumina Body Map 2
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_-_141645645 Show fit | 1.93 |
ENST00000519980.1
ENST00000220592.5 |
argonaute RISC catalytic component 2 |
|
chr19_-_40324255 Show fit | 1.88 |
ENST00000593685.1
ENST00000600611.1 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
|
chr5_+_7396141 Show fit | 1.88 |
ENST00000338316.4
|
adenylate cyclase 2 (brain) |
|
chr16_+_11762270 Show fit | 1.88 |
ENST00000329565.5
|
stannin |
|
chr1_+_145438469 Show fit | 1.82 |
ENST00000369317.4
|
thioredoxin interacting protein |
|
chr5_-_59189545 Show fit | 1.76 |
ENST00000340635.6
|
phosphodiesterase 4D, cAMP-specific |
|
chr6_+_17281573 Show fit | 1.74 |
ENST00000379052.5
|
RNA binding motif protein 24 |
|
chr21_-_28338732 Show fit | 1.67 |
ENST00000284987.5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
|
chr12_-_26278030 Show fit | 1.63 |
ENST00000242728.4
|
basic helix-loop-helix family, member e41 |
|
chr11_+_113930291 Show fit | 1.55 |
ENST00000335953.4
|
zinc finger and BTB domain containing 16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 2.9 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.0 | 2.0 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.1 | 1.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 1.8 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.1 | 1.8 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 1.8 | GO:0002347 | response to tumor cell(GO:0002347) |
0.4 | 1.7 | GO:0044691 | tooth eruption(GO:0044691) |
0.2 | 1.6 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 1.6 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 2.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 2.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 2.0 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 1.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 1.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.1 | 1.1 | GO:0042587 | glycogen granule(GO:0042587) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 2.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 2.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 2.3 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 2.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.5 | 1.9 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.1 | 1.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 1.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 1.8 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 1.6 | GO:0043426 | MRF binding(GO:0043426) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 1.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 1.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.5 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 1.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 2.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 1.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 1.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 1.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 1.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |